PROCW
Procaps Group, S.A.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · LU
$0.02
+33.79%Margins
Gross margin
55.0%
EBITDA margin
29.0%
EBIT margin
22.6%
Net margin
12.6%
FCF margin
8.2%
132.5%
Return on equity
10.5%
Return on assets
28.5%
Return on invested capital
0.84x
Asset turnover
$63.0M
Cash from operations
$0.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2023